SC 13G Filing

Company

Theriva Biologics, Inc.

Filed

October 20, 2014

Accession Number

0000930413-14-004363

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →